VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
This Quarter Return
+7.81%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$753M
AUM Growth
+$753M
(+5.8%)
Cap. Flow
+$5.37M
Cap. Flow
% of AUM
0.71%
Top 10 Holdings %
Top 10 Hldgs %
7.71%
Holding
486
New
110
Increased
121
Reduced
151
Closed
98
Top Buys
| 1 |
FNSR
Finisar Corp
FNSR
|
$3.66M |
| 2 |
S
Sprint Corporation
S
|
$3.25M |
| 3 |
RAX
Rackspace Hosting Inc
RAX
|
$3.13M |
| 4 |
Credicorp
BAP
|
$3.11M |
| 5 |
TTM
Tata Motors Limited
TTM
|
$3.02M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$4.8M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
$4.17M |
| 3 |
Meta Platforms (Facebook)
META
|
$4.13M |
| 4 |
VA
Virgin America Inc.
VA
|
$3.43M |
| 5 |
United Airlines
UAL
|
$3.32M |
Sector Composition
| 1 | Technology | 15.47% |
| 2 | Healthcare | 12.36% |
| 3 | Financials | 10.67% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Industrials | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Pampa Energía
PAM
$3.67B
| $600K | 0.08% |
+18,508
| New | +$600K |
|
327
Inovio Pharmaceuticals
INO
$126M
| $591K | 0.08% |
63,383
| – | – |
|
328
Visa
V
$683B
| $581K | 0.08% |
5,166
-2,970
| -37% | -$334K |
|
|
WBA
329
DELISTED
Walgreens Boots Alliance
WBA
| $562K | 0.07% |
6,966
-2,505
| -26% | -$202K |
|
330
Western Union
WU
$2.8B
| $558K | 0.07% |
26,811
-13,189
| -33% | -$274K |
|
331
TransDigm Group
TDG
$78.8B
| $557K | 0.07% |
1,400
-864
| -38% | -$344K |
|
332
American Tower
AMT
$95.5B
| $553K | 0.07% |
+3,635
| New | +$553K |
|
|
XONE
333
DELISTED
The ExOne Company
XONE
| $553K | 0.07% |
+36,335
| New | +$553K |
|
|
TSRO
334
DELISTED
TESARO, Inc.
TSRO
| $552K | 0.07% |
+5,506
| New | +$552K |
|
335
Bristol-Myers Squibb
BMY
$96B
| $530K | 0.07% |
9,837
-89
| -0.9% | -$4.8K |
|
336
Procter & Gamble
PG
$368B
| $528K | 0.07% |
5,884
-2,766
| -32% | -$248K |
|
337
NetEase
NTES
$86.2B
| $525K | 0.07% |
+2,180
| New | +$525K |
|
|
ADAP
338
Adaptimmune Therapeutics
ADAP
$15.6M
| $516K | 0.07% |
73,145
-427
| -0.6% | -$3.01K |
|
339
Union Pacific
UNP
$133B
| $512K | 0.07% |
+5,249
| New | +$512K |
|
|
ABMD
340
DELISTED
Abiomed Inc
ABMD
| $512K | 0.07% |
3,980
-2,496
| -39% | -$321K |
|
|
NXTM
341
DELISTED
NxStage Medical Inc.
NXTM
| $511K | 0.07% |
+20,435
| New | +$511K |
|
342
Berkshire Hathaway Class B
BRK.B
$1.09T
| $502K | 0.07% |
3,474
-22,433
| -87% | -$3.24M |
|
343
Comcast
CMCSA
$125B
| $502K | 0.07% |
7,567
-31,234
| -80% | -$2.07M |
|
344
Edwards Lifesciences
EW
$47.8B
| $502K | 0.07% |
+4,161
| New | +$502K |
|
345
Eli Lilly
LLY
$657B
| $501K | 0.07% |
6,240
-2,464
| -28% | -$198K |
|
|
STJ
346
DELISTED
St Jude Medical
STJ
| $500K | 0.07% |
+6,268
| New | +$500K |
|
|
ZAYO
347
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $498K | 0.07% |
+16,771
| New | +$498K |
|
348
Crown Castle
CCI
$43.2B
| $497K | 0.07% |
+5,271
| New | +$497K |
|
349
Expedia Group
EXPE
$26.6B
| $497K | 0.07% |
4,259
-1,771
| -29% | -$207K |
|
350
Philip Morris
PM
$260B
| $497K | 0.07% |
+5,115
| New | +$497K |
|